InsidersTradesSigma
Follow the Bioceltix S.A. share price and the full management transaction log of the company, a listed equity based in Poland. Shares are listed on the PL market, under the authority of KNF. Operating in the Health Care sector, Bioceltix S.A. has published 1 reports. Market capitalisation: €445.9m. The latest transaction was disclosed on 18 May 2026 (Notification PDMR). All data is accessible without an account.
1
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Bioceltix S.A. Strong Buy (bullish), based on 1 analysts. Average price target: PLN 133.00.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 18 May 2026
About Bioceltix S.A.
Bioceltix S.A. is a company specialized in the health and pharmaceutical sector. It is listed on the XWAR market.